FDA Inspection
Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited – FDA Inspection, Mar 15, 2019
Record Details
This FDA Inspection record concerns Glenmark Pharmaceuticals Limited, with an inspection on March 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 76994ec3-3b82-446f-9cf1-7c06892b1e58
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1082656
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.166(a)(3)Valid stability test methods
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Glenmark Pharmaceuticals Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 20, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| March 31, 2017 | Not classified | Office of Inspections and Investigations | |
| May 30, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Glenmark Pharmaceuticals Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.